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Infection with a Ratborne Hantavirus in US Residents Is Consistently
Associated with Hypertensive Renal Disease
Gregory E. Glass, Alan J. Watson, James W. LeDuc,*
Gabor D. Kelen, Thomas C. Quinn, and James E. Childs*

Department of Immunology and Infectious Diseases, Johns Hopkins
UniversitySchool of Hygiene and Public Health, and Departmentof
Nephrologyand Divisions of Emergency Medicine and of Infectious
Diseases, Johns Hopkins School of Medicine, Baltimore; Disease
Assessment Division, Department of Epidemiology, US Army Medical
Research Institute of Infectious Diseases, Fort Detrick;Laboratoryof
Immunoregulation,National Institute of Allergy and InfectiousDiseases,
National Institutes of Health, Bethesda, Maryland

A surveyof 8080 subjectswas conductedin Baltimore,examiningthe associationbetween
infectionwithhantaviruses
andrenaldisease.Twogroups(N ^ 6060)withno knownriskfactors
were selected to establisha baselineantibodyprevalence.Overall,antibodyprevalencewas
0.250Zo.
increasedwithage,withoutsex- or race-related
differences.Patientswith
Seroprevalence
showed
the
samepatternsof infectionbutweremorecommonlyseropositive(1.460Zo)
proteinuria
than the referencegroup(OR, 3.23; P < .05). Infectionamongdialysispatientswith end-stage
renaldiseasewas 2.760Zo,
significantlyhigherthanin the referencegroup(OR, 5.03;P < .05). In
the proteinuriaand the dialysisgroups,hantavirusinfectionwas consistentlyassociatedwith a
diagnosisof hypertensiverenaldisease.The associationwas unrelatedto otherchronicrenal
diseasediagnoses.Overall,6.507o
of patientswith end-stagerenaldiseasedue to hypertension
wereseropositivefora hantavirus.
Thesedatasuggestthathantavirusinfectionis associatedwith
hypertensiverenaldisease.
Hantaviruses(family Bunyaviridae),the etiologic agents
of hemorrhagicfever with renal syndrome(HFRS), are distributedworldwide,primarilyin rodentreservoirs[1]. HFRS
varies in severitydepending on the specific infecting hantavirus but is typically defined by fever, transient renal dysfunction, and, less commonly, hemorrhage.Although primarily recognized from Korea, China, Russia, and
Scandinavia,HFRS now is being identifiedfrommany countries in Europe and Asia not previously thought to be endemic for these viruses [2, 3].
Studiesin North Americahave led to the isolation of han-
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tavirusesfrom several species of rodents [4-8], and human
serologicsurveyshave demonstratedantibodiesin geographically and occupationallydiversegroups,rangingfrom forestersto shipyardworkers[7, 9-12]. In the United States,studies using plaque reductionneutralization(PRN) tests with a
libraryof representativehantaviruseshave clearlylinked antibody in humans from Baltimoreto domesticallyacquired
infection with a strainof Seoul virus, a Norway rat (Rattus
hantavirus[10, 11].
norvegicus)-2LSSocmizd
Even though human infection with hantaviruseshas been
demonstratedin the United States,therehave been no documentedcasesof HFRSnorany descriptionsof diseaseaccompanying seroconversionto a hantavirus.A single possible
case of HFRS due to Leakey virus, a house mouse (Mus
musculus)-associatedhantavirus,has been reportedbut not
confirmed[8]. The failureto recognizeHFRS in the United
Stateshas led to the hypothesisthat domestic strainsof hantavirusmay produceasymptomaticinfectionsor atypicaldisease [13] or that human exposuresto these viruses(or contacts with their rodent reservoirs)occur less often than in
other countries.
Despite the absence of acute disease, there is epidemiologic evidence that infection with hantaviruses,even where
endemic HFRS is not recognized,is associatedwith chronic
renal disease. In Baltimore,infection with a ratbornehantavirus, as evidenced by neutralizingantibody,was associated
with hypertensiverenal diseaseand hypertensionamong inner-cityhospitalpatientswith proteinuria[14]. Although recovery from HFRS is usually believed to be complete, reports from locations endemic for the disease also indicate
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that some percentage of patients do suffer long-term sequelae [15-18].
This study was designed to investigate intensively the epidemiology of locally acquired hantavirus infections in Baltimore and to examine the association of infection with
chronic renal disease. We established baseline antibody prevalence to the local Seoul virus strain, Baltimore rat virus, in a
large sample of city residents. Then we prospectively monitored selected inpatients at a large inner-city hospital for antibodies to hantaviruses. Finally, we sampled renal dialysis
patients from four hemodialysis units within the city and
examined the association between hantavirus antibody and
specific diagnoses of renal disease, with the a priori prediction that seropositivity would be positively associated with
hypertensive renal disease [14].
Materials and Methods
Serologic surveys. Four groups were selected for study; two
had no known risk factors for exposure to hantaviruses except
residing in a city that had infected rats [11, 19]. These two
groups, described below, served as a reference sample to provide
background antibody prevalence levels for Baltimore.
The third group was drawn from patients at Johns Hopkins
Hospital (JHH) who received quantitative urine total protein
(UTP) tests. Proteinuriawas used as an inclusion criterion, as it
is a consistent laboratoryfinding in cases of HFRS regardlessof
the causative hantavirus [20-22]. As proteinuriaalso serves as a
general markerof renal dysfunction, this group was used to evaluate the association between hantavirus infection and underlying diagnoses of renal disease.
The fourth group consisted of patients from inner-city Baltimore with end-stage renal disease on maintenance hemodialysis. This group was selected to examine the hypothesis that hantavirus infection is associated with specific chronic renal
sequelae, especially hypertensive renal disease [14].
Sexually transmitted disease (STD) group. Sera were gathered from 2660 patients visiting a Baltimore STD clinic from
March 1985 through March 1988. Interviews were conducted
twice weekly from consecutive willing individuals. Information
on age, sex, race, and residence were obtained from a short questionnaire given orally. Details of data collection procedures and
= 1180) of the
serologic results from a specific subsample (N
STD group were reported previously [11]. Data from the entire
STD group, including the previously reported subsample, are
included here as part of the larger reference sample.
JHH Emergency Department group. Sera were obtained
from 3400 patients as part of an AIDS study conducted by the
JHH Department of Emergency Medicine (ER). Individuals
were enrolled from June to August 1988. Information was gathered on age, sex, race, and zip code of residence. Some sampling
weight was given to the younger age groups. Details of the procedures are described elsewhere [23].
JHH proteinuria group. Sera were obtained from 1766 patients whose physicians requested 24-h UTP tests and blood
chemistry panels from the Blood Chemistry Department at
JHH. Samples were gathered from January 1986 to May 1990
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from all patients with proteinuria ^50 mg/24 h for whom
serum samples were available. Also, the first 2 subjects with
proteinuria< 150 mg/24 h from a randomly selected day in each
week were chosen to form an internal, second referencegroup to
assess the association between hantavirusinfection and proteinuria.
Informationwas obtained on age and sex for all patients. However, racial status was not generally available and could be obtained only by reviewing patients' charts. Medical histories were
obtained from all seropositive and a subsample of age- and sexmatched seronegative patients (see below) by researchers
blinded for serologic status. Details of the proceduresand preliminary findings on the association between hantavirus antibody
and hypertensive renal disease are described elsewhere [14].
Dialysis group. Sera were obtained from 1988 to 1991 from
254 patients with end-stage renal disease. All patients (N = 328)
in four hemodialysis units serving the inner-city area of Baltimore were eligible for the study. Participantsprovided a blood
sample and information on age, sex, race, and residence by zip
code.
The International Classification of Diseases (ICD) code for
the diagnosis of underlying renal disease was obtained from patient records, before serologic testing, and cross-checked with
the patient's primary health care provider. ICD codes were aggregated into diagnostic groups for underlying renal disease
[24]. These groups included hypertensive renal disease (ICD
codes 401. and 403.), diabetic renal disease (codes 250., 583.71,
and 583.81 if diabetes was specified as the underlying cause of
disease), drug nephrotoxicity (code 584.5), glomerulosclerosis
(code 581.), glomerulonephritis (code 582.), nephrolithiasis
(code 592.), polycystic kidney disease (code 753.), and other.
Information on dialysis patients who did not participate in
this study was provided in aggregate without identifiers. These
data were used to check for participation bias on the basis of
demographic and diagnostic variables.
Serologicassays. Hantavirus infection was determined serologically. Initially, all sera were screened at 1:100 dilutions for
IgG to prototype Hantaan virus (strain 76-118) by ELISA [25].
Antigen was derived from Vero-E6-infected cell lysates as described previously [26]. Uninfected Vero-E6 cell lysates were
included in duplicate wells as controls. Samples with optical
densities ^ SD above the mean of 3 negative control sera included on each plate were tested further.
Specific antibody in each positive screen was confirmed by
PRN assays using Baltimore rat virus, Hantaan virus, and Prospect Hill virus, a vole-associated hantavirusisolated from Microtus pennsylvanicuscaptured in Frederick, Maryland [6]. Differential neutralization titers, which vary by 4- to 32-fold among
homologous and heterologous viruses [10, 25], were used to
identify the particular infecting hantavirus. A neutralization
titer of ^1:10 for sera that reduced plaque formation by ^80*20
was considered positive.
Data analysis. Analyses were done with either SAS [27] or
BMDP [28] statistical software systems. Descriptive analyses
were done for all variables, and initial comparisons were made
by contingency table, with calculations of odds ratios (OR) and
95*^confidence intervals (CI) as appropriate. Mantel-Haenszel
weighted ORs were used to compare age-stratified prevalence
data between various groups.
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For analyses exploring the association of hantavirusantibody
and chronic disease in the dialysis group, all frequency variables
were tested with Fisher's exact test or as ORs with CI. Twotailed tests were used in all comparisons.
Conditional logistic regression analysis was done on the JHH
proteinuriagroup with matched seropositive (cases) and seronegative patients (controls). Patients were matched for age (within 3
years) and sex, with 5 randomly selected controls per case. This
analysis included 15 cases that were previously described and
analyzed by univariate methods [14]. Information was obtained
on race, residence (subsequently coded as city resident or not),
current and previous occupation, hospital unit, reason for admission, and the occurrence of any chronic diseases.
Preliminarystudy [ 14] had shown that the only variables that
differed between infected and uninfected individuals were the
presence of hypertensive renal disease, hypertension, and
stroke. Therefore, the initial regression model included these
variables as well as race. Other clinical and demographic variables were subsequently added and were kept in the model only
if they significantly improved the fit of the model to the outcome
of serologic status.
All demographic and clinical data from the JHH proteinuria
patients were obtained by two reviewers independently screening medical charts without prior knowledge of the serologic status of the patients. All demographic and diagnostic data were
obtained from the dialysis group before serologic testing. Statistical examination of primarydiagnoses underlying chronic renal
disease for both the JHH proteinuria and dialysis groups was
done after grouping ICD codes into four categories: no chronic
renal disease, diabetes mellitus, hypertension, and other.

Results
Seroepidemiology
Reference population. Among the two groups selected to
establish background antibody prevalence in Baltimore, 11
patients (0.32^) from the JHH ER and 4 patients (0.157c)
from the STD clinic were seropositive to a hantavirus, as
confirmed by PRN tests. All had highest neutralizing titers to
Baltimore rat virus, suggesting exposure to the local rat-associated hantavirus. There were no statistically significant differences in prevalence between the ER and STD groups by
race, sex, or age, stratified by 20-year age groups (table 1).
On the basis of similarities of low antibody prevalence
across all demographic classifications, the two groups were
combined into a single reference group for further analyses.
Infection patterns in the remaining groups were compared to
those of the reference group. However, as a more conservative test, comparisons also were done using only the ER
group as a standard. There were no differences in the results
using the entire reference group or only the ER group, so
results of the reference group comparisons are shown.
In the reference group, seroprevalence increased from
0.1 \7c in persons ^ 1 years old (^ ^ 1839) to 0.70^ in those
^0 (n = 284; table 2). There were no differences in sero-

Table 1. Prevalence of neutralizing antibody to Baltimore rat
virus, a strain of Seoul virus, in patients visiting Johns Hopkins
EmergencyMedicineDepartment(ER) and a sexuallytransmitted
disease clinic (STD) in Baltimore, 1985-1989.
ER

Variable
Race
African-American
Caucasian
Other
Sex*
Male
Female
Age, years
<21
21-40
41-60
>60

STD

No.
positive/total

%
positive

No.
positive/total

%
positive

9/2474
2/897
0/29

0.36
0.22
0

4/2563
0/83
0/14

0.16
0
0

7/1820
4/1578

0.38
0.25

4/1878
0/782

0.21
0

2/1067
4/1663
3/399
2/271

0.19
0.24
0.75
0.74

0/772
4/1775
0/100
0/13

0
0.23
0
0

cData
missingfor2 subjects.

prevalence associated with race (0.26^ African-Americans
vs. 0.207c all others; OR, 1.32; CI, 0.28-8.48) or sex (0.307c
male subjects vs. 0.17^ female subjects; OR, 1.76; CI,
0.52-6.54).
JHH proteinuria group. Antibody prevalence was \.467c
among patients in the JHH proteinuria population whose
=
1507); 22 of these patients
proteinuria ^50 mg/24 h (n
were seropositive to a hantavirus, and all had highest neutralizing titers to Baltimore rat virus. Seroprevalence also increased with age in this group from zero in those ^ 1 years
old to 2.217c in those ^0 (table 2). ORs of seroprevalence
based on age-stratified comparisons between the JHH proteinuria population and the reference group ranged from
2.69 to 3.68 and were consistently elevated over all strata.
Although statistical significance in each age stratum was precluded by small numbers of seropositive subjects, there was a
significant overall increase in antibody prevalence in the
JHH proteinuria group when adjusted for age (MantelHaenszel weighted OR, 3.23; CI, 1.35-7.44).
As with the reference group, there was no association between hantavirus infection and sex (1.27% male subjects vs.
1.597c female subjects; OR, 0.80; CI, 0.30-2.04). There was
a higher proportion of seropositive subjects among AfricanAmericans than among other races when seropositive subjects were compared with matched controls (see below); however, the difference was not statistically significant (OR,
3.56; CI, 0.92-16.06).
In total, 259 JHH inpatients were sampled who had UTP
tests but showed proteinuria ^50 mg/24 h. In this second,
internal reference group, only 1 patient was seropositive for
hantavirus. Infection was with BRV. The level of association
between hantavirus antibody and the occurrence of protein-
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Table 2. Race, sex, and age-associatedseroprevalenceto Baltimorerat virus based on neutralization antibody tests in reference,proteinuria,and dialysisgroups.
Reference

Variable
Race
African-American
Other
Sex
Male
Female
Age, years
<21
21-40
41-60
>60
Overall

group,
%positive
(nf

Proteinuria
%positive
(n)

Dialysis

OR

%positive
(n)

OR

0.26(5037)
0.20(1023)

?
?

?
?

3.37(208)
0.00(46)

13.46
?

0.30(3698)
0.17(2360)

1.27(628)
1.59(879)

4.32
9.53

2.72(110)
2.78(144)

9.40
16.83

0.11(1839)
0.23(3438)
0.60(499)
0.70(284)
0.25(6060)

0.0(161)
0.62(481)
2.18(367)
2.21(498)
1.46(1507)

?
2.69
3.68
3.18
3.23

?
1.92(52)
0.94(106)
5.43(92)
2.80(250)

?
8.41
1.56
8.10
5.03

NOTE. Proteinuriagroup includes only patients with urine total protein ^50 mg/24 h. Odds ratios(ORs)
use appropriateage class from referencegroup for comparison.OverallORs are weighted Mantel-HaenszelORs.
? , not calculated due to lack of data.
* Includestotal
figuresfrom sexually transmitteddiseaseand Johns HopkinsEmergencyMedicineDepartment
groupsfrom table 1.

uria within the hospital population (OR, 3.82; CI, 0.557.65) was similar to that between the JHH proteinuria group
and the external reference group.
Hemodialysis group. Among patients using hemodialysis
because of end-stage renal disease, hantavirus antibody prevalence was 2.76^ (7/254). All patients had highest neutralizing antibody titers to Baltimore rat virus. Seroprevalence
tended to increase by age stratum, ranging from 1.92^ in
those 21-40 years old (there were no patients sampled in the
^1 years group) to 5.43^ in those ^0 (table 2).
Overall, the dialysis population had a significantly higher
prevalence of infection when stratified by 20-year age categories than the reference group (Mantel-Haenszel weighted
OR, 5.03; CI, 1.50-17.68). There were no significant differences in infection associated with sex (2.127c male subjects
vs. 2.187c female subjects; OR, 0.98; CI, 0.17-5.32) or race
(3.37^ African-American vs. 0.00^ other; P = .36, Fisher's
exact test).
Association with Chronic Disease
JHH proteinuria group. Crude analyses between demographic and clinical features and hantavirus infection indicated that hypertension, stroke, and hypertensive renal disease were associated with the presence of hantavirus
antibodies (table 3). Conditional logistic regression analysis
demonstrated significant correlations among these three variables, and hypertension and stroke did not meet the criterion
for inclusion in the final model.
Race was included in the final model a priori as a factor
known to be confounded with hypertensive disease. By using

conditional logistic regression and controlling for race (table
3), hantavirus-seropositive individuals had a significantly
higher frequency of hypertensive renal disease (OR, 16.19;
CI, 3.05-86.00) than did seronegative hospital patients with
proteinuria (table 3). There was no overall difference in the
frequency of occurrence of the two major chronic diseases
Table 3. Crude and adjusted odds ratios (ORs) and 95*30confidence intervals (CIs) for variable obtained from Johns Hopkins
Hospital proteinuria group analyzed for their associations with hantavirus antibody.
Variable
Residence (city vs. other)
Sex (male vs. female)
Hypertension(presentvs. absent)
Renal disease (none vs. any
etiology)
Stroke(presentvs. absent)
Diabetes mellitus (present vs.
absent)
Hypertensiverenal disease
(presentvs. absent)
Race (African-Americanvs.
other)

Hypertensiverenal disease
(present vs. absent)*
Race (African-Americanvs.
other)*
* Included in conditional

CrudeOR

CI

1.24
0.81
5.20

0.43-3.60
0.21-3.16
1.11-24.41

1.27
3.63

0.92-1.76
1.34-9.86

0.42

0.14-1.28

20.50

6.03-69.70

3.33

0.94-11.82

AdjustedOR

CI

16.19

3.05-86.00

1.26

0.28-5.79

logistic regressionmodel.
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reported for this group, diabetes mellitus (OR, 0.42; CI,
0.14-1.28) and renal disease (OR, 1.27; CI, 0.92-1.76), indicating the specificity of the association. No other clinical or
demographic variable, including residence, was associated
with hantavirus infection (table 3).
Dialysis group. Primary diagnoses for the cause of endstage renal disease were available for all 328 patients who
were using the four hemodialysis units. In this population,
the leading causes of end-stage renal disease were hypertension (40.7^) and diabetes mellitus (29.0^). Other significant
causes of renal disease were glomerulonephritis due to
various causes (1.67c), obstructive uropathies (3.2^), polycystic disease (2.6^), and intravenous drug use (2.27c). There
were no statistical differences by race, sex, or primary disease
diagnosis (based on hypertension, diabetes mellitus, or
other) between those who participated in the study and those
who did not (P > .50 in all tests).
All 7 seropositive patients had hypertensive renal disease
as the primary diagnosis underlying their end-stage renal disease (P = .0018, Fisher's exact test). Overall, among the
hypertensive population with end-stage renal disease, 6.5^
(7/109) were seropositive for a ratborne hantavirus. There
was no significant difference (t = 1.84; P> .05) in the ages of
patients with hypertensive renal disease (mean ? SD, 57.1 ?
15.4 years) and patients with renal disease due to other
causes (54.1 ? 14.4 years).
Discussion
The data presented here complement our previous report
on the association between hantavirus infection and a specific chronic renal disease [ 14]. Although the data are associational and cannot address relevant factors, such as the temporal relationship between infection and the development of
renal disease, they do support the hypothesis of a causal relationship between infection with a ratborne hantavirus and
the development of hypertensive renal disease. First, the
strength of association between hantavirus antibody and hypertensive renal disease is high, resulting in an OR of 16.19
in the proteinuric patient group and a significant association
(P = .0018) in the dialysis group. Second, the association
with hypertensive renal disease is consistent across both patient groups. Finally, the association between hantavirus antibody and hypertensive renal disease was specific to this
diagnosis and unrelated to other chronic renal disease.
Hantavirus infection in rodents in the United States was
demonstrated shortly after the isolation of prototype Hantaan virus nearly a decade ago [29, 30]. Several hantaviruses
have been isolated from different rodent species and from
varied geographic sites in the continental United States [48]. Subsequent serologic surveys documented human infection by hantaviruses in US residents [7, 9-12]. However, no
definite acute cases of HFRS have been reported, although
disease consistent with HFRS has been noted in 3 seroconverting patients among the JHH proteinuria group [31].
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In the absence of well-defined domestic cases of HFRS,
various hypotheses have been proposed to explain the reasons for global variation in disease patterns. These potential
explanations include that infection by domestic strains of
hantaviruses may be less virulent and produce subclinical or
atypical disease and that the frequency of infection may be so
low that the few cases of disease go unrecognized. Although
there are increasing data from restriction pattern analyses
and sequence comparisons demonstrating strain variation
among hantaviruses, little information is available to link
these patterns to HFRS cases of differing severity [32, 33].
However, serologic surveys do provide insights on the
level of hantavirus infection in various geographic locations.
Our current and previous studies demonstrate that overall
hantavirus infection rates are lower in Baltimore than in
areas endemic for HFRS. Antibody prevalence in the reference group (0.25^) is an order of magnitude lower than has
been reported from cross-sectional surveys from either European (1.97c in Sweden [34]) or Asian (3.8^o in Korea [35])
HFRS-endemic locations. These comparisons suggest that
lower domestic exposure may contribute to the difficulties in
recognizing acute disease if it occurs. However, the data from
Baltimore are conservative estimates of infection, as they are
based on results confirmed by PRN tests, while results from
other locations are based solely on indirect fluorescent antibody tests or ELISA.
The pattern of infection in Baltimore also differs somewhat from surveys of HFRS cases from regions endemic for
the disease, indicating that the epidemiology of transmission
also may vary. In Baltimore, there was no difference in antibody prevalence between male and female subjects in any of
the groups surveyed. Cases of HFRS typically show a male
bias of 5-6:1 in HFRS-endemic locations, presumably reflecting occupational exposures [34-36], although the distribution of hantavirus antibody may be less disparate [35].
This difference suggests that exposure in inner-city populations to ratborne hantaviruses may occur in or near residences, rather than at the workplace [37]. As such, the primary at-risk group in the United States may be urban
residents rather than rural populations, as is the pattern in
HFRS-endemic locations [37].
Although background antibody prevalence was low, the
JHH proteinuria group had a roughly threefold increase in
infection rate compared with that of the age-stratified reference group. As proteinuria is a consistent clinical feature of
HFRS, such a finding suggested an association between infection with a hantavirus and some acute renal dysfunction.
However, r^157c of the seropositive patients in the proteinuria group had serologic tests on paired sera collected over
periods of weeks that revealed unchanging titers (unpublished data). This indicated their antibody was presumably
the result of infection in the past, and their current proteinuria, if related to hantavirus infection, was a manifestation of
long-term or chronic disease.
The observation that hantavirus infection was also three-
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fold higheramong the patients with proteinuriathan in the
internalreferencegrouptested for UTP but without proteinuriais consistentwith the associationof hantavirusinfection
and renal dysfunction. It appearsunlikely that the association is an artifact of the selection process, as seropositive
subjectsdid not differfromseronegativesubjectsin any demographiccharacteristic,and the overallprevalenceof chronic
renaldiseasedue to any factordid not differbetween the two
groups(table 3). The absence of any indicativedemographic
factor,including area of residenceand occupation, suggests
that socioeconomicfactorsdid not differbetween the groups.
However, it is likely that exposureto rats per se is linked to
economic conditions [37].
The statistical association of hantavirus infection with
chronic renal disease also is consistent with our long-term
observationsof the 3 patients from the proteinuriapopulation who showed changing antibody titers, indicating seroconversion following acute hantavirus infection (unpublished data). Two of the 3 patientswere subsequentlynoted
to have evidence of chronic renal dysfunction (serum urea
nitrogen^2 mg/dL; serum creatinine> 1.2 mg/dL) for > 1
year, and 1 of these patients developed end-stagerenal disease requiringmaintenancehemodialysis.The patient had a
diagnosisof hypertensiverenal disease determinedindependently of serologicstatus.
The consistentfindingthat distinguishesbetween the hantavirus antibody-positive patients and the uninfected patients is the association with hypertensive renal disease.
Nearly 75^ of the infected JHH proteinuriagroupand all of
the seropositivedialysispopulationhad this diagnosisas the
underlying cause of their renal disease. Hantavirusesare
known to preferentiallyinfect vascularendothelialcells [38]
and possibly renal tubular epithelium [39]. Acute vascular
endothelial damage is recognizedas the majorcause of pathology in HFRS [40]. Damage to these target cells could
producethe basic lesions resultingin the observedrenaldysfunction in acute cases. Our data supporta hypothesisthat
these lesions resultin permanentvascularor tubulardamage
that contributes to the later development of hypertensive
renal disease.
Previously,most studieshave reportedcomplete although
protractedrecoveryfrom HFRS. Exceptions are the reports
in the Russianliteratureindicating9^ of 85 patientsdeveloped "elevated arterial pressure" 1-10 years after acute
HFRS [17], and a study by Rubini et al. [15]. They noted
that 2-5 years after apparentrecoveryfrom HFRS, 7 of 13
patients had acquiredhyposthenuria,and 2 of 13 had developed hypertensive vascular disease. In addition, they reported 1 case of chronic glomerulonephritisand 2 cases of
pyelonephritisamong 31 cases after presumptiverecovery.
Most recently, Kleinknecht and Rollin [41] have observed
the development of hypertensionin 2 patientsafter HFRS.
Otherauthorshave not highlightedfindingssuggestiveof
chronicrenal sequelae following acute HFRS [42, 43]. Only
Lahdevirta'sstudy [42] providessufficientdetail to reexam-

619

ine this issue. His data (table 21 in [42]) show that ~70^ of
his patientsin follow-upfromHFRS were hypertensive(diastolic ^9 mm Hg), and 20*20
of the patients had diastolic
blood pressuresof ^95 mm Hg. Nearly 30^ had decreased
renal function. More recent prospective studies of smaller
numbersof patientsfromareasendemic for HFRS also show
that 10^-^
of patients subsequently develop persistent
renal dysfunction and essential hypertension [44]. An increasedprevalenceof hantavirusantibodyin patientpopulations with renal disease also has been reportedfrom countrieswhereHFRS is rareor unreported,such as Ireland[45].
As these studies involve different hantaviruses(Hantaan,
Seoul, and Puumala),the occurrenceof chronicrenaldisease
in a proportionof individualsappearsto be a common characteristicof hantavirusinfection, whether or not acute disease is apparent.
If these results are confirmed, they would suggest that
some fractionof the substantialnumberof cases of hypertensive renal disease and resultinghypertensionin the United
Statesmay be of infectiousorigin.Domestic exposureto ratborne hantaviruseswould presumablybe greatestin the inner cities of the United States [37]. However, the problem
could be global, given the worldwidedistributionof Seoul
virusand Rattusspecies [46]. Futureresearcheffortsshould
focus on confirmingthis observedassociationin other populationsand on prospectivefollow-upin HFRS-endemiclocations of largenumbersof confirmedHFRS patientsover periods sufficientfor establishinga diagnosisof chronic renal
disease.
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